Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Josh Prince

Josh Prince is recorded as COO at Vistagen Therapeutics, Inc. (VTGN). Josh Prince has spoken on 5 earnings calls across 1 company, most recently for Vistagen Therapeutics, Inc. on February 13, 2025.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Vistagen Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.